Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1373 SynBAd, a clinical cancer vaccine candidate, induces antigen-specific T cells and extends life in a therapeutic liver cancer model
Compose a Response to This Article
Other responses
No responses have been published for this article.